GE HealthCare Technologies Inc.
WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
FIGI: BBG01BFR8YV1
GEHC
GE HealthCare Technologies Inc.
GICS: -
·
Sektor: Healthcare
·
Sub-Sektor: Health Information Services
NAME
GE HealthCare Technologies Inc.
ISIN
US36266G1076
TICKER
GEHC
MIC
XNAS
REUTERS
GEHC.OQ
BLOOMBERG
GEHC US
F&G:
76
Financial Intelligence
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Mo., 07.07.2025
GE HealthCar
US36266G1076
GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2025 financial results before the market opens on Wednesday, July 30, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor...
GE HealthCar
Di., 01.07.2025
GE HealthCar
US36266G1076
The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2025 payable on August 15, 2025 to all shareholders of record as of July 25, 2025.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global heal...
GE HealthCar
Di., 24.06.2025
GE HealthCar
US36266G1076
GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has approved an updated label for its positron emission tomography (PET) imaging agent VizamylTM (flutemetamol F 18 injection) for beta-amyloid detection. The revised label, effective immediately, expands the indications for use, enables quantitative anal...
GE HealthCar
Mo., 23.06.2025
GE HealthCar
US36266G1076
GE HealthCare’s commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on full display at this week’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in New Orleans, Louisiana.
As cardiovascular disease (CVD) continues to rise globally,i the need for advanced diagnostic tec...
GE HealthCar
Sa., 21.06.2025
GE HealthCar
US36266G1076
At this year’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of theranostics-enabling solutions designed to help drive clinical and operational excellence. Making its debut, GE HealthCare’s MIM Software introduces LesionID Pro with ...
GE HealthCar
Do., 19.06.2025
GE HealthCar
US36266G1076
Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions being the development and research of innovative total body PET/CT technology.i This effort is expected to explore new clinical pathways and help enhance patient outcomes thr...
GE HealthCar
Do., 12.06.2025
GE HealthCar
US36266G1076
GE HealthCare (Nasdaq: GEHC) proudly announces the combination of GE HealthCare’s proprietary features and algorithms with MIM Encore, marking a significant milestone in its mission to deliver precision care through advanced digital solutions. This implementation brings powerful new features to healthcare organizations boasting GE HealthCare syste...
GE HealthCar
Fr., 30.05.2025
GE HealthCar
US36266G1076
GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for clinicians now recommend considering fluoroestradiol (FES) positron emission tomography (PET) for systemic staging in patients with recurrent or metastatic lobular breast cancer. GE HealthCare’s Cerianna™ (fluoroestradiol F18)...
GE HealthCar
Do., 15.05.2025
GE HealthCar
US36266G1076
GE HealthCare (Nasdaq: GEHC) today announced the launch of CleaRecon DL, technology powered by a deep-learning algorithm, to improve the quality of cone-beam computed tomography (CBCT) images. This artificial intelligence (AI)-driven solution is designed to remove streak artifacts caused by the pulsatile nature of blood flow in the arteries and ch...
GE HealthCar
Di., 13.05.2025
GE HealthCar
US36266G1076
GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company’s Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) ultrasound enhancing agent (UEA). This approval will help improve the clarity and diagnostic accuracy of echocardiograms in pedia...
GE HealthCar
Informationen zu Product Placements
BARRISTA SMART * AD
P R O D U C T S U G G E S T I O N S
